Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

First approval for Aricept

Nov. 27, 1996

Fujisawa antidementia agent in clinical stage

Nov. 27, 1996

Initial human safety studies completed for CoCensys' stroke drug

Nov. 27, 1996

Ebselen on track for NDA filing in Japan

Nov. 27, 1996

Clinical results reported for rhIGF-I in ALS patients

Nov. 27, 1996

New antioxidant from Shiseido shows CNS activity

Nov. 27, 1996

Takeda discloses new agents for neurodegenerative disorders

Nov. 27, 1996

Lilly claims new indication for olanzapine

Nov. 26, 1996

Worldwide rights offered for protein inducing oligodendroglia mitosis

Nov. 26, 1996

Novel antipsychotic drug now available in U.K.

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...